Biogen vs Eli Lilly: Jim Cramer hnyav hauv

Shares ntawm Biogen Inc (NASDAQ: BIIB) poob txog 8.0% rau hnub Wednesday tom qab US Medicare qhov kev pab cuam tsis kam them rau nws cov tshuaj Alzheimer, Aduhelm, tshwj tsis yog tus neeg mob tau cuv npe hauv kev tshawb fawb soj ntsuam pom zoo.

CMS tus thawj coj cov lus hais ntawm CNBC's 'Squawk ntawm Txoj Kev'

Biogen tau ntseeg siab tias kev pabcuam yuav pab txog 50,000 tus neeg mob pib kho xyoo no, tab sis cov lus tshaj tawm tsis suav nrog ntau yam uas tuaj yeem tau txais txiaj ntsig.


Puas yog koj tab tom nrhiav kom tau cov xov xwm ceev, kub-cov lus qhia thiab kev tsom xam kev ua lag luam?

Sau npe rau Invezz cov ntawv xov xwm, hnub no.

Piav qhia txog qhov laj thawj tom qab CED (kev pab them nqi nrog pov thawj kev txhim kho), Chiquita Brooks-LaSure, Lub Chaw rau Medicare thiab Medicaid Services tus thawj coj, tau hais rau CNBC's "Squawk ntawm Txoj Kev":

Peb xav kom paub tseeb tias nws tsim nyog rau Medicare cov pej xeem. Yog vim li cas peb pab neeg tau piav qhia txog tej yam uas peb xav pom hauv kev sim tshuaj. Tab sis qhov no yog ib qho kev txiav txim siab. Peb zoo siab tos txais cov neeg koom nrog los tawm tswv yim thiab yuav tshaj tawm qhov kev txiav txim zaum kawg tom qab.

Thaum Lub Kaum Ob Hlis, Biogen txo tus nqi ntawm Aduhelm los ntawm kwv yees li 50% rau $ 28,200 uas ntau tus tseem ceeb toom tuaj yeem yog lub nra hnyav rau tsoomfwv txoj kev pab them nqi kho mob.

Vim li cas Cramer nyiam Lilly ntau dua li Biogen

CMS xav tias yuav muab nws qhov kev txiav txim zaum kawg rau lub Plaub Hlis 11th. Txhua yam nws txiav txim siab yuav siv dav rau tag nrho cov tshuaj no, suav nrog kev sim tshuaj hauv kev txhim kho ntawm Eli Lilly & Co (NYSE: LLY).

Tsis tas li ntawd hnub Wednesday, Jim Cramer tau hais tias Lilly yuav yeej Biogen hauv Alzheimer's. Hauv kev sib tham cais ntawm CNBC's "Squawk ntawm Txoj Kev", nws hais tias:

Tus yeej yuav yog Lilly. CEO Ricks tau muab kev nthuav qhia zoo heev nag hmo ntawm JPMorgan thiab hais tias peb cov kev xeem sib txawv heev. Lawv muaj qhov kev sim loj dua uas tuaj yeem thim rov qab cov quav hniav. Thiab kuv tsis xav tias nws puas tau npaj them tus nqi qis tshaj uas Biogen them rau Aduhelm.

Lilly poob ze li ntawm 10% hauv tsawg dua ib hlis, uas, raws li Cramer, yog qhov yuam kev. Cov xov xwm tuaj ntau tshaj li ib hlis tom qab Biogen poob qhov kev thov rov hais dua ntawm nws cov tshuaj ntau yam sclerosis, Tecfidera.

Ua lag luam nyob rau hauv crypto, stocks, ETFs & ntau dua hauv feeb nrog peb tus neeg nyiam ua haujlwm,

eToro






10/10

67% ntawm cov khw muag khoom CFD tso nyiaj poob

Tau qhov twg los: https://invezz.com/news/2022/01/12/biogen-vs-eli-lilly-jim-cramer-weighs-in/